8 November 2025
Latham & Watkins Advises 4D Molecular Therapeutics on US$100 Million Offering of Common Stock and Pre-Funded Warrants
Advising firms
Deal team
17 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mark Roeder Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| John Williams Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Raul Gonzalez-Casarrubias | Latham & Watkins LLP | Associate | corporate | Not stated |
| Lexi Zintel | Latham & Watkins LLP | Associate | corporate | Not stated |
| Keran Huang | Latham & Watkins LLP | Associate | corporate | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | regulatory | Washington, D.C. |
| Evan Miller | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy and cybersecurity | Bay Area |
| Sarah Zahedi | Latham & Watkins LLP | Associate | data privacy and cybersecurity | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Dennis Poehland | Latham & Watkins LLP | Associate | tax | Not stated |
| Maj Vaseghi | Latham & Watkins LLP | Partner | benefits and compensation | Bay Area |
| Christopher Hazuka | Latham & Watkins LLP | Partner | intellectual property | San Diego/Bay Area |
| Robert Yeh | Latham & Watkins LLP | Counsel | intellectual property | San Diego |
| Kristina Funahashi | Latham & Watkins LLP | Associate | intellectual property | Not stated |
Stated terms
- Stated value
- USD 100m (US$100 million)
- What the figure measures
- Issue size
- Client
- 4D Molecular TherapeuticsIssuer
- Counterparties
- Not stated